Rare diseases
Investigational molecules
Locations
328 conditions with trials, the busiest first
865 trials across Europe, recruiting first
A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
CzechiaA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
BulgariaStudy of Telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus
BulgariaStudy on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis
CzechiaStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
AustriaStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
BulgariaStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
BulgariaAdd‑on Unsaturated Fatty Acids with TNF‑Alpha Inhibitor Drug Combination in Patients with Psoriatic Arthritis
ItalyPhase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease
BelgiumOptimizing biologic tapering in patients with rheumatoid arthritis using tocilizumab, drug combination, and olfactory placebo conditioning
The NetherlandsPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
CzechiaLong‑term study of Pompe disease in all patients receiving alglucosidase alfa drug combination (miglustat, cipaglucosidase alfa, avalglucosidase alfa)
The NetherlandsThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
